TGS Announces New Proprietary 2D Survey Offshore Colombia
September 24, 2012 01:50 ET
|
TGS ASA
HOUSTON (24 September 2012) - TGS has signed an agreement with Colombia's Agencia de Hidrocarburos (ANH) to acquire a new 10,000 km proprietary 2D survey offshore Colombia. Approximately 6,400 km of...
ALM Equity: ALM Equity förvärvar fastighet i Nacka
September 24, 2012 01:38 ET
|
ALM Equity AB
Stockholm, 2012-09-24 07:38 CEST (GLOBE NEWSWIRE) --
ALM Equity har tillsammans med investerare förvärvat fastigheten Sicklaön 361:1 i Nacka. Köpeskillingen uppgår till 29 Mkr. Affären görs i...
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR) - Net Asset Value(s)
September 24, 2012 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} BOUSSARD &...
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP) - Net Asset Value(s)
September 24, 2012 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} BOUSSARD...
Results from Novartis Phase III study show that RLX030 reduced deaths in patients with acute heart failure
September 24, 2012 01:15 ET
|
Novartis Pharma AG
RELAX-AHF study met one of its two primary endpoints in reducing dyspnea or shortness of breath, and showed RLX030 (serelaxin) was well tolerated[1] Six-month study shows that investigational...
Results from Novartis Phase III study show that RLX030 reduced deaths in patients with acute heart failure
September 24, 2012 01:15 ET
|
NOVARTIS FINANCE S.A.
RELAX-AHF study met one of its two primary endpoints in reducing dyspnea or shortness of breath, and showed RLX030 (serelaxin) was well tolerated[1] Six-month study shows that investigational...
EGIDE : Résultats au 30 juin 2012
September 24, 2012 01:00 ET
|
EGIDE
Trappes, le 24 septembre 2012 - 07:00 (CET)Communiqué de presse Résultats au 30 juin 2012 Le conseil d'administration s'est réuni le 21 septembre 2012 sous la présidence de Philippe Brégi...
Addex mGluR4 Allosteric Modulator Effective in Multiple Sclerosis Model - A Novel Oral Small Molecule Approach for the Treatment of Multiple Sclerosis
September 24, 2012 01:00 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 24 September 2012 - Addex...
Full Year Results for the year ended 31 July 2012
September 24, 2012 01:00 ET
|
ARYZTA AG
Zurich / Switzerland, 24 September 2012 - ARYZTA AG announces financial results for the financial year ended 31 July 2012. The news release can be downloaded from the following link: ...
East Capital Explorer AB - Rapport om återköp av egna aktier i East Capital Explorer
September 24, 2012 01:00 ET
|
East Capital Explorer AB
East Capital Explorer AB meddelar att bolaget, inom ramen för styrelsens beslut
om att utnyttja återköpsbemyndigandet som meddelades den 7 augusti 2012, har
återköpt 40 635 aktier under perioden 17...
- June 09, 2024 09:02 ET Optimove Insights Releases the 2024 Consumer Summer Shopping Report
- June 08, 2024 17:09 ET Stockholder Alert: Robbins LLP Informs Investors of the Class Action Lawsuit Filed Against The Scotts Miracle-Gro Company